El cancro al seno xe el cancro pì comun tra łe done in tuto el mondo, co un stimà de 2,3 milioni de novi casi diagnosticà nel 2020, secondo l'Organixasion Mondiałe deła Sanità (OMS).
Nei Stati Uniti, el cancro al seno xe el secondo cancro pì comun tra e done, co 281.5500 novi casi stimà che sarà diagnosticà nel 2021, secondo l'American Cancer Society.
El riscio de na dona de ciapar el cancro al seno nel corso dea vita xe de 1 su 8 o circa del 12,9%.
PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html
RefinedWeb https://arxiv.org/abs/2306.01116
Zhang ML, Huang ZZ, Zheng Y: [Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (10): 1049-51.
Peng J, Ganry O, Tramier B, Dubreuil A, Raverdy N, Thulliez A: [Incidence and prevalence estimations for breast and colorectal cancer in the Picardy region]. Rev Epidemiol Sante Publique. 2002, 50 (5): 427-32.
Liu FC, Lin HT, Kuo CF, See LC, Chiou MJ, Yu HP: Epidemiology and survival outcome of breast cancer in a nationwide study. Oncotarget. 2017, 8 (10): 16939-16950.
Asadzadeh Vostakolaei F, Broeders MJ, Mousavi SM, Kiemeney LA, Verbeek AL: The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: a projection to 2030. Breast. 2013, 22 (3): 277-81.
Runco R, Laganà S, Marino G, Di Grazia A, Marino L, Umina V, Girlando A, Ricottone N, D'Agostino A, Marletta F, Tamburo M, Corsaro G, Rallo F, Santacaterina A, Acquaviva G, Crispi M, Palazzolo C, Platania A, Spatola C, Privitera G, Frosina P, Garufi G, Bonanno S, Rosso A, Barone V, Corallo A, Sansotta G, Delia P, Donato V, Lopes S, Pisana M, Borzì F, Iatì G, Potami A, Messina G, Parisi S, Frosina L, Marletta D, De Renzis C, Pontoriero A, Pergolizzi S: Breast cancer bone metastases: an epidemiologic study in selected radiation departments. Tumori. , 100 (1): 38-41.
['Sto sito web el xe fornìo solo par scopi educativi e informativi e no el costituise un consejo mèdego o servisi profesionali.']
['Łe informasion fornìe no łe ga da esar usà pa diagnosticar o curar un problema de salute o na malatia, e chi che serca un consijo mèdego personal el ga da consultar un mèdego licensià.']
['Te prego de notare che a rete neurałe che ła genera risposte ałe domande, ła xe particołarmente imprecisa quando se trata de contenuti numèrici, par exenpio el nùmaro de persone a cui xe stà diagnosticà na determinada małatia.']
['Serca senpre el consijo del to dotor o de un altro fornitor de sałute cualificà riguardo a na condision mèdega. Mai trascurar el consijo mèdego profesionałe o ritardarlo nel sercarlo par via de calcossa che te ghè leto su sto sito. Se te pensi de aver na emergensa mèdega, ciama el 911 o va al pronto socorso pì visin imediatamente.']
['El Digital Millennium Copyright Act del 1998, 17 U.S.C. § 512 (el DMCA) el dà ricorso ai proprietari de copyright che i crede che el material che vien fora su Internet infranga i so diriti soto ła lege sui copyright dei Stati Uniti. ']
["Se te credi in bona fede che un contenuto o un material messo a dispoxision in conesion col nostro sito o i nostri servisi infranga i to diriti de autor, ti (o el to agente) te pol mandarne na notisia domandando che el contenuto o el material sia rimoso, o che l'acesso sia blocà."]
['I avixi i ga da esare mandà par scrito via e-mail (varda ła sezion "Contato" pa\'l indiriso e-mail).']
["El DMCA richiede che a to notisia de presunta violasion de copyright includa e seguenti informasion: (1) descrixion del lavoro proteto da copyright che xe l'ogeto de ła presunta violasion; (2) descrixion del presunto contenuto che viola e informasion sufisente par permeterne a noi de localixar el contenuto; (3) informasion de contato, incluxo el to indirizo, numero de telefono e indirizo email; (4) na dichiarasion da parte tua che te credi in bona fede che el contenuto nel modo reclamà no xe autorizà dal proprietario del copyright, o dal so agente, o da l'operasion de nisuna lege; "]
["(5) 'na to dichiarasion, firmada soto pena de spergiuro, che łe informasion neła notìfega xe precise e che te ghè l'autorità de far valer i diriti de autor che i xe stai violadi;"]
['e (6) na firma fisica o ełetrònica del titołare del copyright o de na persona autorizada a agire a nome del titołare del copyright. ']
['Se no te meti tute łe informasion sora łe pol far in modo che el tratamento del to reclamo el se intardi.']
['Ve prego de mandarne na mail co qualsiasi domanda/suggerimento.']
Breast cancer is the most common cancer among women worldwide, with an estimated 2.3 million new cases diagnosed in 2020, according to the World Health Organization (WHO). The incidence and prevalence of breast cancer vary by region, but it is a significant health concern globally.
In the United States, breast cancer is the second most common cancer among women, with an estimated 281,5500 new cases expected to be diagnosed in 2021, according to the American Cancer Society.
The lifetime risk of a woman developing breast cancer is approximately 1 in 8, or about 12.9%. However, it is important to note that these numbers are estimates and may vary based on factors such as age, genetics, lifestyle, and environmental factors.
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['BioMedLib usa computer automatici (algoritmi de machine-learning) pa generar coppie de domande e risposte.']
['Cominsiemo co 35 milioni de publicassioni biomediche de PubMed/Medline. e anca pagine web de RefinedWeb.']
['Varda "Riferimenti" anca "Disclaimer".']